In response to continued interest in Tabex, today we take a
more in-depth look at this smoking cessation medication and the latest published data on its efficacy. A randomized, controlled trial of 740 smokers
from Poland showed that significantly more participants receiving Tabex
maintained smoking abstinence at 6 months and 1 year compared with those
receiving placebo.
“There are still regulatory hoops to go through but I hope
that before long this drug will be available throughout the world at a cost
that every smoker can afford," lead author Robert West, PhD, told Medscape Medical News.
"It should be cheaper to take this drug than to smoke,
wherever you are in the world. It is not a magic cure by any means; stopping is
still extremely difficult for many people. But it could save many hundreds of
thousands of lives if not millions, which is quite a thought", he added.
Tabex is currently not available in the UK, but
varecniline (Champix), a closely related and effective medication is available. If you are interested in quitting smoking contact us on
0207 882 8230 and we can advise on attending our clinic or provide details of
stop-smoking service in your area.
No comments:
Post a Comment